NEUROPACE, INC. Operating Cash Flow
NEUROPACE, INC. (NPCE) reported Operating Cash Flow of -$9.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-11
- NEUROPACE, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$3.90M.
- NEUROPACE, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$5.90M.
- NEUROPACE, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $506.00K.
- NEUROPACE, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.94M.
- NEUROPACE, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$11.01M.
- NEUROPACE, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$17.95M.
- NEUROPACE, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$19.70M.
- NEUROPACE, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$36.87M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$9.80M 10-Q · filed 2026-08-11 | -$9.30M derived: sum of 3 quarters · filed 2026-08-11 | -$11.24M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$5.90M 10-Q · filed 2026-05-12 | -$5.39M derived: sum of 2 quarters · filed 2026-05-12 | -$7.34M derived: sum of 3 quarters · filed 2026-05-12 | -$9.42M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $506.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$1.44M derived: sum of 2 quarters · filed 2026-03-03 | -$3.52M derived: sum of 3 quarters · filed 2026-08-11 | -$11.01M 10-K · filed 2026-03-03 |
| 2025-09-30 | -$1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$4.03M derived: sum of 2 quarters · filed 2026-08-11 | -$11.51M 10-Q · filed 2025-11-04 | -$16.31M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$9.57M 10-Q · filed 2026-08-11 | -$14.37M derived: sum of 3 quarters · filed 2026-08-11 | -$16.09M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$7.48M 10-Q · filed 2026-05-12 | -$12.28M derived: sum of 2 quarters · filed 2026-05-12 | -$14.00M derived: sum of 3 quarters · filed 2026-05-12 | -$17.90M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$6.52M derived: sum of 2 quarters · filed 2026-03-03 | -$10.42M derived: sum of 3 quarters · filed 2026-03-03 | -$17.95M 10-K · filed 2026-03-03 |
| 2024-09-30 | -$1.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$5.62M derived: sum of 2 quarters · filed 2025-11-04 | -$13.15M 10-Q · filed 2025-11-04 | -$16.49M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$3.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$11.43M 10-Q · filed 2025-08-12 | -$14.77M derived: sum of 3 quarters · filed 2025-08-12 | -$17.07M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$7.53M 10-Q · filed 2025-05-13 | -$10.87M derived: sum of 2 quarters · filed 2025-05-13 | -$13.17M derived: sum of 3 quarters · filed 2025-05-13 | -$17.53M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$5.64M derived: sum of 2 quarters · filed 2025-03-04 | -$10.00M derived: sum of 3 quarters · filed 2025-03-04 | -$19.70M 10-K · filed 2025-03-04 |
| 2023-09-30 | -$2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$6.66M derived: sum of 2 quarters · filed 2024-11-12 | -$16.36M 10-Q · filed 2024-11-12 | -$24.20M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$4.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$14.06M 10-Q · filed 2024-08-13 | -$21.90M derived: sum of 3 quarters · filed 2024-08-13 | -$28.88M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$9.70M 10-Q · filed 2024-05-08 | -$17.54M derived: sum of 2 quarters · filed 2024-05-08 | -$24.52M derived: sum of 3 quarters · filed 2024-05-08 | -$35.17M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$7.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$14.82M derived: sum of 2 quarters · filed 2024-03-05 | -$25.48M derived: sum of 3 quarters · filed 2024-03-05 | -$36.87M 10-K · filed 2024-03-05 |
| 2022-09-30 | -$6.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$17.63M derived: sum of 2 quarters · filed 2023-11-06 | -$29.03M 10-Q · filed 2023-11-06 | -$37.23M derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | -$10.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$22.05M 10-Q · filed 2023-08-08 | -$30.25M derived: sum of 3 quarters · filed 2023-08-08 | -$34.68M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$11.39M 10-Q · filed 2023-05-04 | -$19.60M derived: sum of 2 quarters · filed 2023-05-04 | -$24.02M derived: sum of 3 quarters · filed 2023-05-04 | -$30.03M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | -$8.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$12.63M derived: sum of 2 quarters · filed 2023-03-02 | -$18.64M derived: sum of 3 quarters · filed 2023-03-02 | -$24.58M 10-K · filed 2023-03-02 |
| 2021-09-30 | -$4.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$10.44M derived: sum of 2 quarters · filed 2022-11-08 | -$16.37M 10-Q · filed 2022-11-08 | -$22.80M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$6.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$11.95M 10-Q · filed 2022-08-11 | -$18.37M derived: sum of 3 quarters · filed 2022-08-11 | -$23.80M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$5.94M 10-Q · filed 2022-05-12 | -$12.36M derived: sum of 2 quarters · filed 2022-05-12 | -$17.79M derived: sum of 3 quarters · filed 2022-05-12 | -$21.00M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$6.42M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$11.85M derived: sum of 2 quarters · filed 2022-03-10 | -$15.06M derived: sum of 3 quarters · filed 2022-03-10 | -$21.61M 10-K · filed 2022-03-10 |
| 2020-09-30 | -$5.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$8.64M derived: sum of 2 quarters · filed 2021-11-10 | -$15.19M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$3.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$9.76M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$6.55M 10-Q · filed 2021-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |